Compare Davita Inc (DVA) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Davita Inc trades at $179.02 (market cap $11.38B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $59.88. The key difference: JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | JEPQ | |
|---|---|---|
Market Cap | $11.38B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $240.96 | $61.46 |
52-Week Low | $103.87 | $53.77 |
Enterprise Value | $24.10B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
